ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro operating margin
Operating margin is operating income as a percentage of revenue.
ClearPoint Neuro's operating margin for the twelve months ending Sep 30, 2026 was -70.6%. For fiscal 2025 it was -65.4%, against -62.9% the year before. The highest annual figure on record is -41.0% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -65.4% | −2.5 |
| FY2024 | Dec 31, 2024 | -62.9% | +30.8 |
| FY2023 | Dec 31, 2023 | -93.7% | −14.2 |
| FY2022 | Dec 31, 2022 | -79.5% | +2.6 |
| FY2021 | Dec 31, 2021 | -82.1% | −33.6 |
| FY2020 | Dec 31, 2020 | -48.5% | −7.5 |
| FY2019 | Dec 31, 2019 | -41.0% | +30.4 |
| FY2018 | Dec 31, 2018 | -71.4% | +14.5 |
| FY2017 | Dec 31, 2017 | -85.9% | +44.4 |
| FY2016 | Dec 31, 2016 | -130.3% | +65.1 |
| FY2015 | Dec 31, 2015 | -195.3% | −47.7 |
| FY2014 | Dec 31, 2014 | -147.6% | +42.6 |
| FY2013 | Dec 31, 2013 | -190.2% | −128.3 |
| FY2012 | Dec 31, 2012 | -61.9% | +93.2 |
| FY2011 | Dec 31, 2011 | -155.1% | +201.4 |
| FY2010 | Dec 31, 2010 | -356.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -52.4% | +7.1 |
| Q2 FY2026 | Jun 30, 2026 | -94.2% | −32.5 |
| Q1 FY2026 | Mar 31, 2026 | -69.9% | +2.7 |
| Q4 FY2025 | Dec 31, 2025 | -67.7% | +4.9 |
| Q3 FY2025 | Sep 30, 2025 | -59.5% | +4.0 |
| Q2 FY2025 | Jun 30, 2025 | -61.6% | −1.5 |
| Q1 FY2025 | Mar 31, 2025 | -72.6% | −17.4 |
| Q4 FY2024 | Dec 31, 2024 | -72.5% | −3.4 |
| Q3 FY2024 | Sep 30, 2024 | -63.5% | +21.5 |
| Q2 FY2024 | Jun 30, 2024 | -60.1% | +59.7 |
| Q1 FY2024 | Mar 31, 2024 | -55.2% | +49.9 |
| Q4 FY2023 | Dec 31, 2023 | -69.1% | +17.3 |
| Q3 FY2023 | Sep 30, 2023 | -85.0% | −11.2 |
| Q2 FY2023 | Jun 30, 2023 | -119.8% | −39.0 |
| Q1 FY2023 | Mar 31, 2023 | -105.1% | −28.3 |
| Q4 FY2022 | Dec 31, 2022 | -86.4% | +6.6 |
| Q3 FY2022 | Sep 30, 2022 | -73.7% | +9.4 |
| Q2 FY2022 | Jun 30, 2022 | -80.8% | +19.0 |
| Q1 FY2022 | Mar 31, 2022 | -76.8% | −22.7 |
| Q4 FY2021 | Dec 31, 2021 | -93.0% | −32.0 |
| Q3 FY2021 | Sep 30, 2021 | -83.2% | −47.0 |
| Q2 FY2021 | Jun 30, 2021 | -99.8% | −40.3 |
| Q1 FY2021 | Mar 31, 2021 | -54.1% | −15.3 |
| Q4 FY2020 | Dec 31, 2020 | -61.0% | −16.8 |
| Q3 FY2020 | Sep 30, 2020 | -36.1% | −5.0 |
| Q2 FY2020 | Jun 30, 2020 | -59.5% | −9.9 |
| Q1 FY2020 | Mar 31, 2020 | -38.8% | +0.5 |
| Q4 FY2019 | Dec 31, 2019 | -44.2% | −1.2 |
| Q3 FY2019 | Sep 30, 2019 | -31.1% | +35.6 |
| Q2 FY2019 | Jun 30, 2019 | -49.6% | +49.8 |
| Q1 FY2019 | Mar 31, 2019 | -39.3% | +48.6 |
| Q4 FY2018 | Dec 31, 2018 | -43.0% | +66.1 |
| Q3 FY2018 | Sep 30, 2018 | -66.7% | +10.6 |
| Q2 FY2018 | Jun 30, 2018 | -99.4% | −7.1 |
| Q1 FY2018 | Mar 31, 2018 | -87.9% | −20.5 |
| Q4 FY2017 | Dec 31, 2017 | -109.1% | +0.4 |
| Q3 FY2017 | Sep 30, 2017 | -77.3% | – |
| Q2 FY2017 | Jun 30, 2017 | -92.2% | – |
| Q1 FY2017 | Mar 31, 2017 | -67.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -109.5% | – |
See a number that looks wrong?